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ABSTRACT
OBJECTIVE: The objective of this selective EBM review is to determine whether honey used as
adjunctive therapy is effective in alleviating nasal allergy symptoms.
STUDY DESIGN: This is a systematic review of three randomized controlled trials published
between 2010-2013, all in the English language.
DATA SOURCES: Three randomized controlled trials, which studied the effects of honey used
as adjunctive therapy for the relief of nasal allergy symptoms, these were obtained using
PubMed.
OUTCOMES MEASURED: The outcome of each study was a patient reported decrease in the
number of days and the severity of nasal allergy symptoms including: sneezing, itching, nasal
blockage, and rhinorrhea. These outcomes were measured via daily diary entries, questionnaires
regarding symptom severity and need for medication, Sino-Nasal Outcome Test (SNOT-22)
questionnaire, and a 7-point visual analog symptom severity scale.
RESULTS: All three RCTs determined that nasal allergy symptoms were decreased a
statistically significant amount, as defined by a p-value <0.05, with the addition of honey in
subject’s daily medication regimen. This was compared to control, which consisted of patients
taking only their normal daily medication and no honey products or a visually and taste matched
placebo.
CONCLUSIONS: The results of this systematic review have demonstrated that honey is
effective in alleviating nasal allergy symptoms in numerous mediums including nasal spray as
well as oral intake when produced in the geographic area in which the patient population resides.
Whilst positive and promising results were obtained from these studies, additional research with
larger patient populations, standardized honey product, and increased time frame of study is
required to ascertain how beneficial honey truly is and if these benefits last.
KEY WORDS: honey, allergic rhinitis
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INTRODUCTION:
The number of people worldwide who suffer from allergies is steadily increasing;
whether it be from air pollution, improved hygiene, or increased indoor allergen exposure, the
exact cause for this escalation remains unknown.1 Allergic rhinitis, also identified as “allergic
rhinosinusitis” or “AR,” is an extremely common disorder affecting upwards of 40 million
people in the U.S.2 It is reported that AR is the cause of, “at least 2.5 percent of all clinician
visits, 2 million lost school days, 6 million lost work days, and 28 million restricted work days
per year.” 3 Currently, AR affects 10-30% of children and adults in the U.S., making it inevitable
that healthcare providers will encounter this disease.3
AR is attributable to a host of triggers including: pollen, mold, animal dander, and dust
mites. When allergy sufferers encounter an allergen, the immune system produces antibodies,
immunoglobulin E (IgE), to the allergen.4 IgE antibodies bind with mast cells, plasma cells and
eosinophils, which within minutes produce symptoms such as sneezing and itching. 2 Hours later,
the late phase of reaction occurs producing nasal congestion and malaise. 2 AR comprises
numerous symptoms including: sneezing, itching, nasal congestion, and rhinorrhea. As the nasal
mucosa and the sinuses are adjoining, patients with sinusitis also concomitantly experience nasal
symptoms.3 AR may affect sufferers in a seasonal pattern or for many, is a constant year-round
struggle. For something as trivial in many people’s minds as “seasonal allergies,” the cost to
manage this disease has become astronomical. In February 2011, it was reported that
approximately $3.4 billion were spent on allergic rhinitis with almost half due to the cost of
prescriptions and over the counter medications.5 Furthermore, research has shown sufferers of
AR have an average number of prescriptions double that of non-sufferers.3 With this being said,
cost effective alternative methods have become a necessity.
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There are numerous accepted methods used to treat the myriad of symptoms comprising
allergic rhinitis. First and foremost, allergen avoidance is encouraged. 6 However, since it is near
impossible to avoid pollen, fungus, mold, or dust in the air, other options must be employed to
combat the immune system’s exaggerated response. For suffers with mild or episodic symptoms,
oral second-generation antihistamines including cetirizine, loratadine, fexofenadine are
effective.6 Gold standard treatment for persistent or moderate to severe AR is glucocorticoid
nasal sprays including: mometasone furoate, fluticasone furoate, and triamcinolone acetonide.6
In addition to an oral second-generation antihistamine or a glucocorticoid nasal spray, patients
can augment their treatment by adding: antihistamine nasal sprays such as olopatadine or
azelastine, a mast cell stabilizer such as Cromolyn sodium, an anti-leukotriene such as
Montelukast, or combination products consisting of an oral antihistamine plus a decongestant.6
More expensive and time consuming yet, is allergen immunotherapy. As many of the abovementioned products are now over the counter, patients have the ability to self-medicate, and this
comes with risks. Many of these products can be sedating, especially if a patient chooses a firstgeneration antihistamine for example, diphenhydramine. Due to their anti-cholinergic properties
these medications can cause urinary retention, altered mental status or confusion, blurred vision,
dizziness, and other adverse drug reactions.6
The usual methods of treatment discussed for nasal allergy symptoms while effective,
have potentially adverse side effects or undesirable dosing schedules, which limit their use in
certain patients; in addition, maximum relief is often never achieved. This leaves patients to
continue to battle daily with their symptoms and search for other options. One of these suggested
options, a natural and safe alternative, is honey. Honey has been recognized as an antioxidant,
antibacterial, antiviral, anti-inflammatory, and immunomodulating substance.7 The proposed use
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of honey is supported by its immunomodulation and anti-inflammatory properties. In animal
studies, honey has been proven to reduce circulating IgE levels, suppress histamine release,
prevent the production of TNF-α and COX-2, and reduce the creation of nitric oxide.7,8 With the
rising costs of healthcare and the wide availability of natural alternatives, it is proposed that
honey be considered as a cost-effective alternative adjunctive method to patient’s normal daily
medication regimen in relieving nasal allergy symptoms. In this systematic review, the
effectiveness of honey in decreasing nasal allergy symptoms will be evaluated through three
randomized controlled trials.
OBJECTIVE
The objective of this selective EBM review is to determine whether or not honey, as
adjunctive therapy, is effective in alleviating nasal allergy symptoms.
METHODS
The population studied in this systematic review was obtained from three randomized
controlled trials which included patients suffering from physician diagnosed nasal allergy
symptoms. Oral consumption of honey or inhalation of honey solution in addition to the patient’s
traditional allergy medication regimen were the interventions reviewed. In Asha'ari et al.
patients, minimum of 18 years of age, were treated with a second generation antihistamine
(Loratidine 10mg) for 4 weeks.8 Loratidine was then discontinued for the remaining 4 weeks of
the study and was replaced with honey or placebo. The case group was given Tualang honey,
raw and unprocessed, and the control a honey flavored corn syrup as placebo to be ingested at 1g
per kg of body weight.8 Thamboo et al. had subjects, 19 years of age and up with a diagnosis of
allergic fungal rhinosinusitis who had failed standardized treatment methods, spray 2mL of a
50/50 mixture of honey and saline into one nostril nightly with a mucosal atomization device.
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The other nostril, which received no honey spray, was utilized as the control; this solution was in
addition to their usual daily medication regimen for 30 days.9 Saarinen et al. compared two
types of honey: a locally collected, unpasteurized and unfiltered organic honey (“regular honey”
or “RH”) against the very same honey enriched with bee-collected pollen from Birch trees,
deemed “Birch pollen honey” (“BPH”) versus control, which consisted of patients on their
regular allergy medication.10 Patients were instructed to ingest the honey daily starting in
November at <1g and increasing the dose at 3 week intervals to a maximum of 8g until the end
of March.10 Reduction in nasal allergy symptoms was the result assessed in each study.
The key words employed in the author’s search for sources via PubMed included
“honey,” and “allergic rhinitis.” Articles utilized in this systematic review were selected from
published peer- reviewed journals in the English language. Articles were chosen if they included
outcomes which were patient oriented (POEMs) and if they related to the author’s clinical
question. Articles selected fit the inclusion criteria of: randomized controlled trials published
after 2010 with no other systematic review, meta-analysis, or articles published in the Cochrane
database regarding the same clinical question. Exclusion criteria consisted of any patient with a
known hypersensitivity to bees or honey. Noted statistics include p-value, mean change from
baseline, and standard deviation.
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Table 1: Demographics and Characteristics of Included Studies
Study

Type
RCT

#
Pts
40

Age
(years)
20-50

Asha'ari,
2013

Thamboo,
2011

RCT

38

19+

Saarinen,
2010

RCT

61

8-79

Inclusion Criteria
Patients 18 years
+ with a
diagnosis of
allergic rhinitis
using clinical
history and
positive skin
prick test. Must
be
willing to
consume a
considerable
amount of honey.
Patients who had
undergone
bilateral
functional
endoscopic sinus
surgery with a
definitive
diagnosis of
allergic fungal
rhinosinusitis
who failed
budesonide
irrigations for <12
weeks and have
tried a course of
systemic
antifungals and
steroids.
Patients with
physician
diagnosed pollen
allergy suffering
from nasal,
conjunctival, and
other allergy
symptoms.

Exclusion
Criteria
Known
hypersensitivity
to honey, history
of asthma,
diabetes, or other
chronic illness,
history of allergy
desensitization
for the past 5
years, or
pregnancy.

W/D

Interventions

Not
reported

1g/kg of
Tualang
honey daily
in separate
doses for four
weeks in
addition to
10mg of
Loratadine.

Patients allergic
to pollen, honey,
or bees.

4

2mL nasal
spray of
50/50 honeysaline
solution using
a mucosal
atomization
device in
selected
nostril once a
day (at night)
for 30 days in
addition to
regular nasal
regimen.

No mentioned
exclusion
criteria.

11

Each patient
consumed
honey on a
daily basis
starting with
<1g in
November
and
increasing
intake to 1 tsp
(about 8g)
until the end
of March.
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OUTCOMES MEASURED:
In this review three RCTs were employed, two single blind and one double blind, with
the measured outcomes being POEMs. The POEMs measured in this review were improvement
(reduction) of allergic nasal symptoms including: sneezing, nasal obstruction, rhinorrhea,
hyposmia, and nasal itching as well as decreased need for usual medication. This was ascertained
using diary entries including daily symptom severity, questionnaires regarding symptoms and
need for medication, Sino-Nasal Outcome Test (SNOT-22) questionnaire, and a 7-point visual
analog scale to evaluate symptom severity score. All data was continuous and was statistically
measured by means of the patient’s self-reported decrease in nasal allergy symptoms or
decreased need for daily medication displayed as mean change from baseline and p-values
assessed against the control group for comparison.
RESULTS:
To determine if the effect of honey on nasal allergy symptoms was advantageous the
three articles being evaluated in this systemic review claimed a statistically significant outcome
was obtained if the consequential p-value was <0.05. The data statistically analyzed from all
three studies was continuous, therefore a mean change in baseline was reported. In Asha'ari et
al. no significant differences were reported between the experimental and control groups in terms
of the mean total symptom score (i.e. the severity of symptoms) at the onset of the study as well
as no significant differences between the groups according to demographics. Forty patients were
utilized and were split evenly between control and experimental arms of the study.8 Reported
time intervals were from weeks 0-4, weeks 4-8, and weeks 0-8.8 Those patients in the
experimental group reported statistically significant decreases in their nasal allergy symptoms
from weeks 0-4, 4-8, and 0-8 as demonstrated in tables 2, 3, 4 and 5.8 In contrast, the control
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arm (placebo) also noted a statistically significant decrease in nasal allergy symptoms from
weeks 0-4; however, from weeks 4-8 there was no longer any noteworthy reduction reported.8 In
this study, we focus on weeks 4-8, which highlights singularly the use of honey versus placebo.
Table 2: Mean total symptom score comparison between experimental arm and control 8
Week
0-4
4-8
0-8

Difference in total symptom
score: Experimental
3.05 (4.76)
2.30 (3.28)
5.35 (4.98)

P- value:
Experimental
0.010
0.005
0.000

Difference in total
symptom score: Control
2.10 (4.15)
1.03 (3.54)
3.13 (4.10)

P- value:
Control
0.036
0.209
0.003

Table 3: Change in mean from baseline symptom severity score from weeks 0-4 8
Experimental Mean P- value
Control Mean
P- value
Symptom
Nasal itchiness
Sneezing
Nasal blockage
Rhinorrhea

difference (SD)
0.45 (0.95)
0.48 (0.88)
0.42 (0.95)
0.38 (0.44)

0.046
0.031
0.043
0.063

difference (SD)
0.45 (1.19)
0.23 (0.84)
0.19 (0.44)
0.56 (0.78)

0.107
0.244
0.121
0.052

Table 4: Change in mean from baseline symptom severity score from weeks 4-8 8
Symptom
Nasal itchiness
Sneezing
Nasal blockage
Rhinorrhea

Experimental Mean
difference (SD)
0.30 (0.47)
0.32 (0.89)
0.39 (0.78)
0.25 (0.49)

P- value
0.010
0.047
0.04
0.112

Control Mean
difference (SD)
0.10 (0.64)
0.18 (0.54)
0.39 (0.87)
0.14 (0.38)

P-value
0.494
0.124
0.087
0.135

Table 5: Change in mean from baseline symptom severity score from weeks 0-8 8
Symptom
Nasal itchiness
Sneezing
Nasal blockage
Rhinorrhea

Experimental Mean
difference (SD)
0.75 (0.97)
0.80 (1.32)
0.81 (1.11)
0.63 (0.72)

P- value
0.03
0.025
0.021
0.044

Control Mean
difference (SD)
0.55 (0.94)
0.41 (0.74)
0.58 (1.01)
0.70 (0.72)

P-value
0.17
0.045
0.115
0.77

Thamboo et al. utilized honey as a nasal spray for patients with nasal allergy symptoms
due to allergic fungal rhinosinusitis. Subjective nasal allergy symptoms were recorded via the
Sino-Nasal Outcome Test (SNOT-22) pre and post study (4 weeks in length).9 Out of the 38
subjects involved in this study, 20 completed both the pre and post SNOT-22 questionnaire. A
significant improvement in nasal allergy symptoms was expressed by sixteen out of the twenty
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patients in this study, as evidenced by a p-value of 0.0220.9 In this trial, four patients claimed
“burning sensation” in their sinuses however, this did not alter their compliance with the study,
and one patient claimed the honey solution induced nausea and subsequently discontinued
participation in the study.9
Saarinen et al. divided subjects into 3 groups: control receiving no honey products, those
receiving birch pollen honey (BPH), and those receiving regular honey (RH). 10 Here, we focus
on the BPH group. Patients were given diaries in which daily recordings of: sneezing, runny,
itchy, or blocked nose were documented. Patients were additionally responsible for a
questionnaire which rated daily symptoms and need for medication. Of the original 61 subjects
in this study, 11 dropped out.10 Subjects in the BPH group demonstrated increased days
symptom free, decreased days with nasal symptoms, and decreased need for nasal medication
compared to control. In regard to symptomatic days, the BPH group had the most significant
change, p-value < 0.01.10 Those patients in the BPH group also showed a statistically significant
decrease in the need for nasal antihistamines p-value <0.001 when compared to control.10 See
Table 6 for results.
Table 6: Number of days with allergy symptoms and use of nasal antihistamine
medication10
# of days
Symptom free
Nasal symptoms
Use of nasal spray

BPH
32.1 + 14.2
23.0 + 12.9
8.0 + 13.5

RH
26.6 + 16.5
29.8 + 20.5
13.4 + 23.4

Control
14.1 + 12.6
44.2 + 12.3
19.5 + 22.0

P-value
0.004
0.001
0.247

In addition, “better general health” and a reduction in number of colds and stomach upset was
reported by 35% of those who used the birch pollen honey and 38% in the regular honey group. 10
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DISCUSSION:
Honey is a reasonably safe adjunctive method to augment the treatment of nasal allergy
symptoms. In the three articles discussed, minimal side effects were mentioned including: mild
itching of mouth or skin, dislike for taste, burning sensation in the sinuses, and nausea.8,9,10
However, it should be noted that those who suffer from allergy to bees or honey should not
incorporate this therapy into their daily routine due to the risk of anaphylaxis. 10 Patients are also
advised to never administer honey products to children less than one year in age due to the risk
of botulism. If patients choose to utilize honey as adjunctive therapy they unfortunately would
have to pay for it out of pocket, potentially limiting access to this method of care. However,
depending on where the honey is purchased, it is relatively low in cost when compared to the
price of standard allergy medications. The studies discussed in this systematic review establish
the potential worth as well as the effectiveness of utilizing honey as an adjunctive therapy in
reducing nasal allergy symptoms. While all three of these studies demonstrated a statistically
significant reduction in symptoms, there are limitations to each.
In Asha'ari et al. the improvement demonstrated in both the control and experimental
groups from week 0-4 can be attributed to the use of Loratidine during this time.8 However, the
data displays patients in the control arm of the study no longer had any improvement of their
symptoms in the subsequent weeks (as Loratadine was discontinued in both groups at week 4).
This suggests that the use of honey unaided in the experimental group from weeks 4-8 was
effective in reducing patient’s symptom severity score.8 The strength of this study was that it
utilized honey alone as treatment after week 4, thus any improvement in symptoms is credited to
the use of honey. The downfall of this study was the small patient population utilized, 20
subjects in the experimental group and 20 in control.8
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Thamboo et al. demonstrated that nasal inhalation of a honey-saline mixture did produce
a statistically significant improvement in allergic nasal symptoms in those patients who filed a
SNOT-22 questionnaire pre and post-study.9 This study is limited by the fact that patients acted
as their own control, therefore the improvement in their symptoms could be attributed to the fact
that patients were not truly blinded.9 In addition, this study was thirty days in length. Most
notably, the questionnaire utilized incorporated other allergic symptoms therefore a decrease in
the total score could have been due to improvement of symptoms other than nasal. Regardless,
inhalation of the honey saline solution did improve symptom severity and this warrants deeper
investigation. If this study was expanded to include a larger patient population, the length of the
study was increased, and a more accurate way to blind patients was instilled, a more reliable
interpretation of the effect of honey on nasal symptom severity could be obtained.
Saarinen et al. established that the use of either regular honey or birch pollen honey
resulted in less need for nasal antihistamine spray, fewer days with nasal symptoms, and
increased number of symptom free days.10 All of which had statistically significant results. The
strength of this study was that it utilized a “preloading period” in which patients consumed
honey in five preseason months, November through March.10 This study highlights the benefit of
augmenting natural raw honey with additional pollen as demonstrated by subjects decreased
symptoms and reduced need for nasal antihistamines. The extended length of this study allows
one to deduce the potential benefits of honey employed as natural allergen desensitization.10
Limitations of this study are that both the experimental groups contained more patients than
control; BPH group: 25 patients, RH: 19 patients, control: 17 patients.10 This could have skewed
statistics in favor of the experimental groups. This study also employs a relatively small patient
population.
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The outcomes of these three studies are limited as the type of honey used was not
standardized, therefore the results could be said to only apply to that one particular type of honey
in that one specific location. Therefore, sufferers of nasal allergy symptoms can find relief in
using honey produced in their geographic area of residence. The time period in which honey was
administered to patients also affects the outcome of this review. In order to validate the use of
honey as adjunctive therapy, a specific time period in which honey is administered would need to
be regulated. There were also numerous approaches taken in which patients rated the severity of
their symptoms, if a universal method to score symptom severity were utilized, a more
conclusive, standardized result could be obtained.
CONCLUSION:
The conclusion deduced from these three studies is that honey is a safe and effective
adjunctive method of reducing the severity of nasal allergy symptoms in suffers of the same
geographic area in which the honey was produced. A statistically significant decrease in
symptom severity was achieved in patients who used honey in addition to their routine allergy
medication regimen in all three studies. In order to entirely validate the effectiveness and the
success of honey in reducing nasal allergy symptoms, more research would need to be completed
with a greater patient population. Furthermore, it would be advantageous to perform additional
research on the time frame in which patients employ the addition of honey into their daily
routine. This could demonstrate if there is increased effectiveness in “preloading” the body prior
to allergy season for those who specifically suffer from seasonal allergies. It would also be
advantageous to research the potential long-term benefits of honey use, if any exist.
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